Note: Staff in 26 pharmacies that did not offer pharmacist-prescribed contraception at the time of the study did not answer a question eliciting whether they expected to offer the service in the future (recorded by research assistants as yes, no, maybe, or don't know).
OBJECTIVE:
In 4 states, which include California, pharmacists can now prescribe hormonal contraception directly to patients. 1, 2 Expanding pharmacists' scope of practice to include prescribing contraception is 1 strategy for increasing a woman's ability to initiate and continue contraceptive use effectively. In 2017, we found that pharmacist-prescribed contraception was available in 11.1% of California pharmacies, with no statistically significant differences by urbanicity or pharmacy type (chain vs independent). 3 Here, we examine expectations of offering this service in the future among those pharmacies that do not offer pharmacist-prescribed contraception.
STUDY DESIGN:
An audit, or mystery shopper, study of a representative sample of California community-based retail pharmacies (n¼1058) was conducted from FebruaryeApril 2017. 3 The Committee for the Protection of Human Subjects at the University of California, Berkeley, did not consider this study to constitute human subjects research. Trained research assistants called each pharmacy to assess availability of pharmacist-prescribed contraception, primarily speaking with pharmacists (96.1% of calls). 3 When pharmacist-prescribed contraception was not available (n¼896), the research assistants asked whether this service would be available in the future, obtaining data from 870 pharmacies. Using Stata statistical analysis software (version 15; Stata Corporation, College Station, TX), we described whether pharmacy staff expected this service to be available and used chi-square tests to examine differences by pharmacy type (independent or chain [5 locations]) and urbanicity.
RESULTS:
Of 870 pharmacies that did not offer pharmacist-prescribed contraception, 33.6% of the pharmacies (95% confidence interval [CI], 30.5e36.8%) indicated that they would offer it in the future; 12.3% of the pharmacies (95% CI, 10.2e14.7%) reported that they would not; 25.2% of the pharmacies (95% CI, 22.4e28.1%) reported that they might; and 29.0% of the pharmacies (95% CI, 26.0e32.1%) reported that they did not know (Table) . By pharmacy type, 35.7% (95% CI, 32.1e40.0%) of chain and 28.0% (95% CI, 22.7e34.0%) of independent pharmacies expected that pharmacist-prescribed contraception would be available in the future; independent pharmacies were more likely to indicate that they would not offer this service in the future; chain pharmacies more frequently indicated they might or did not know (P<.001). Among chain pharmacies, 7.2% (95% CI, 5.4e9.5%) indicated they would not offer pharmacist-prescribed contraception in the future, compared with 25.5% (95% CI, 20.4e31.4%) of independent pharmacies. By setting, more urban pharmacies (35.5%; 95% CI, 32.1e39.0%) indicated that they would offer this service than nonurban pharmacies (22.2%; 95% CI, 15.8e30.4%); more than one half (54.8%; 95% CI, 46.0e63.3%) of nonurban pharmacies did not know about future availability, compared with 24.6% (95% CI, 21.6e27.8%) of urban pharmacies (P<.001). CONCLUSION:
One year after California pharmacists were authorized to prescribe contraception, most pharmacies that did not offer this service indicated they would or were uncertain about offering it in the future. A minority of pharmacy staff responded that this service would not be offered in the future. One study limitation is that the beliefs about future service provision that were expressed by the pharmacy staff who responded to our query may not reflect the pharmacy's actual plans; this is especially salient for chain pharmacies, where decision-making may not occur in individual stores. For this reason, the data from independent pharmacies, which indicated lower expectations of future service provision, may be more realistic. Finally, these data reflect expectations about future availability of this service in pharmacies and should not be conflated with individual pharmacists' intent or willingness to prescribe contraception. 4 Currently, California pharmacies are not reimbursed by health insurance for prescribing contraception, with many opting to directly charge patients a service fee.
2,3 Although California's Medicaid program must reimburse pharmacists by July 2021, 5 the current lack of financial incentives, time constraints, and liability concerns may outweigh pharmacists' interest in providing this service. 4 To realize the promise of increased contraceptive access, research should continue to examine the implementation of pharmacist-prescribed contraception to determine strategies to alleviate barriers to offering this service. 
